https://astx.com/wp-content/uploads/2019/11/logo_white.png00webadminhttps://astx.com/wp-content/uploads/2019/11/logo_white.pngwebadmin2012-10-09 09:10:382016-11-24 13:03:42Astex Pharmaceuticals Earns $5 Million for First Commercial Sale of DACOGEN(R) in the European Union
https://astx.com/wp-content/uploads/2019/11/logo_white.png00webadminhttps://astx.com/wp-content/uploads/2019/11/logo_white.pngwebadmin2012-09-28 09:17:202016-11-24 13:03:05DACOGEN(R) Approved in the European Union for the Treatment of Acute Myeloid Leukemia
https://astx.com/wp-content/uploads/2019/11/logo_white.png00webadminhttps://astx.com/wp-content/uploads/2019/11/logo_white.pngwebadmin2012-09-21 09:19:502016-11-24 13:02:29Astex Pharmaceuticals Discontinues Amuvatinib Clinical Development Program
https://astx.com/wp-content/uploads/2019/11/logo_white.png00webadminhttps://astx.com/wp-content/uploads/2019/11/logo_white.pngwebadmin2012-09-06 09:24:212016-11-24 13:01:54Astex Pharmaceuticals, Cancer Research Technology and The Institute of Cancer Research Announce Epigenetic Drug Discovery Collaboration
https://astx.com/wp-content/uploads/2019/11/logo_white.png00webadminhttps://astx.com/wp-content/uploads/2019/11/logo_white.pngwebadmin2012-09-04 09:27:102016-11-24 13:01:36Astex Pharmaceuticals to Participate on Epigenetics Panel at Rodman & Renshaw Conference
https://astx.com/wp-content/uploads/2019/11/logo_white.png00webadminhttps://astx.com/wp-content/uploads/2019/11/logo_white.pngwebadmin2012-08-20 09:29:142016-11-24 13:01:20Astex President Awarded Prous Institute-Overton and Meyer Award for New Technologies in Drug Discovery
https://astx.com/wp-content/uploads/2019/11/logo_white.png00webadminhttps://astx.com/wp-content/uploads/2019/11/logo_white.pngwebadmin2012-07-24 09:33:082016-11-24 13:00:50Astex Pharmaceuticals to Announce 2012 Second Quarter Financial Results on July 30,
